Neochem Bio Solutions shares opened at ₹108 apiece on NSE SME. This means that the IPO allottees made 10% gain over the ...

Senti Bio reports encouraging SENTI-202 AML trial results as the FDA grants RMAT status, with strong response rates, durable ...

Vor Biopharma (VOR) stock gains as J.P. Morgan issues an Overweight recommendation for the company, citing a blockbuster ...

Investing.com -- Senti Biosciences (NASDAQ:SNTI) stock surged 29% after the company reported positive clinical trial results for its cancer therapy SENTI-202 and received FDA Regenerative Medicine ...

Structure's aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech's stock up nearly 103% as ...

Seventy-three pharmaceutical, biotechnology and medical device companies from mainland China filed for IPOs in Hong Kong this year, a review by BioWorld found. In the second half of 2025, 43 new ...

After a series of unfortunate regulatory rejections and manufacturing issues surfaced, Regeneron’s shares dipped to $483 this ...

The stock listed at Rs 108, a 10.20% premium to the IPO price, and is currently up 4.54% over the listing price. It touched a ...

Eos Energy Enterprises (NASDAQ:EOSE) Director Russell Monoki Stidolph recently sold shares in two separate transactions totaling approximately $11.4 million. On December 5, 2025, Stidolph sold 500,000 ...

Oxford BioDynamics ( ($GB:OBD) ) just unveiled an update. Oxford BioDynamics Plc announced that it will release its financial results for the year ...

Licensing partner Zydus brings extensive commercial experience, marketing more than 225 FDA-approved medicines, providing a ...

MARTINSRIED, Germany, Dec. 9, 2025 /CNW/ — Zydus Lifesciences Limited (including its subsidiaries and affiliates), an innovation-led life-sciences ...